AIRLINK 67.95 Increased By ▲ 2.75 (4.22%)
BOP 5.62 Increased By ▲ 0.05 (0.9%)
CNERGY 4.54 Decreased By ▼ -0.02 (-0.44%)
DFML 25.71 Increased By ▲ 1.19 (4.85%)
DGKC 69.40 Decreased By ▼ -0.56 (-0.8%)
FCCL 20.05 Decreased By ▼ -0.25 (-1.23%)
FFBL 30.45 Increased By ▲ 1.34 (4.6%)
FFL 9.80 Decreased By ▼ -0.03 (-0.31%)
GGL 10.06 Increased By ▲ 0.05 (0.5%)
HBL 114.21 Decreased By ▼ -0.04 (-0.04%)
HUBC 130.75 Increased By ▲ 1.65 (1.28%)
HUMNL 6.71 No Change ▼ 0.00 (0%)
KEL 4.44 No Change ▼ 0.00 (0%)
KOSM 4.83 Decreased By ▼ -0.06 (-1.23%)
MLCF 36.70 Decreased By ▼ -0.30 (-0.81%)
OGDC 132.30 No Change ▼ 0.00 (0%)
PAEL 22.56 Increased By ▲ 0.02 (0.09%)
PIAA 25.77 Decreased By ▼ -0.12 (-0.46%)
PIBTL 6.61 Increased By ▲ 0.01 (0.15%)
PPL 113.21 Increased By ▲ 0.36 (0.32%)
PRL 29.24 Decreased By ▼ -0.17 (-0.58%)
PTC 15.12 Decreased By ▼ -0.12 (-0.79%)
SEARL 57.30 Increased By ▲ 0.27 (0.47%)
SNGP 65.71 Decreased By ▼ -0.74 (-1.11%)
SSGC 10.91 Decreased By ▼ -0.07 (-0.64%)
TELE 8.67 Decreased By ▼ -0.13 (-1.48%)
TPLP 11.56 Decreased By ▼ -0.14 (-1.2%)
TRG 68.65 Increased By ▲ 0.03 (0.04%)
UNITY 23.56 Increased By ▲ 0.16 (0.68%)
WTL 1.35 Decreased By ▼ -0.03 (-2.17%)
BR100 7,346 Increased By 50.9 (0.7%)
BR30 23,993 Increased By 138.9 (0.58%)
KSE100 70,596 Increased By 306.3 (0.44%)
KSE30 23,240 Increased By 68.7 (0.3%)
World

EU drugs agency meeting to discuss Moderna COVID-19 vaccine

  • The EMA's human medicines committee (CHMP) had been scheduled to meet on Wednesday.
  • In the event that the CHMP reaches an opinion at today's meeting, we would send out a press release as soon as possible after the meeting,
Published January 4, 2021

AMSTERDAM: The European Medicines Agency (EMA) was holding a meeting on Monday, two days ahead of schedule, that could decide to recommend approving Moderna's COVID-19 vaccine, a spokesperson said.

The EMA's human medicines committee (CHMP) had been scheduled to meet on Wednesday.

The agency has set a Jan. 12 deadline for whether to recommend Moderna's vaccine. It recommended a COVID-19 vaccine from Pfizer and its German partner BioNTech on Dec. 21.

"In the event that the CHMP reaches an opinion at today's meeting, we would send out a press release as soon as possible after the meeting," it said in a statement.

A CHMP meeting scheduled for Wednesday was still planned "in case the committee does not reach a decision today," it added.

Comments

Comments are closed.